PuSH - Publication Server of Helmholtz Zentrum München

Systems medicine advances in interstitial lung disease.

Eur. Respir. Rev. 26:170021 (2017)
Publ. Version/Full Text Research data DOI
Open Access Gold
Creative Commons Lizenzvertrag
Fibrotic lung diseases involve subject-environment interactions, together with dysregulated homeostatic processes, impaired DNA repair and distorted immune functions. Systems medicine-based approaches are used to analyse diseases in a holistic manner, by integrating systems biology platforms along with clinical parameters, for the purpose of understanding disease origin, progression, exacerbation and remission.Interstitial lung diseases (ILDs) refer to a heterogeneous group of complex fibrotic diseases. The increase of systems medicine-based approaches in the understanding of ILDs provides exceptional advantages by improving diagnostics, unravelling phenotypical differences, and stratifying patient populations by predictable outcomes and personalised treatments. This review discusses the state-of-the-art contributions of systems medicine-based approaches in ILDs over the past 5 years.
Additional Metrics?
Edit extra informations Login
Publication type Article: Journal article
Document type Review
ISSN (print) / ISBN 0905-9180
e-ISSN 1600-0617
Quellenangaben Volume: 26, Issue: 145, Pages: , Article Number: 170021 Supplement: ,
Publisher European Respiratory Society
Reviewing status Peer reviewed